CN108018240A - A kind of middle gluconacetobacter and its application - Google Patents
A kind of middle gluconacetobacter and its application Download PDFInfo
- Publication number
- CN108018240A CN108018240A CN201711434866.3A CN201711434866A CN108018240A CN 108018240 A CN108018240 A CN 108018240A CN 201711434866 A CN201711434866 A CN 201711434866A CN 108018240 A CN108018240 A CN 108018240A
- Authority
- CN
- China
- Prior art keywords
- bacteria cellulose
- gluconacetobacter
- temperature
- time
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/02—Acetobacter
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
Abstract
The invention discloses a kind of middle gluconacetobacter (Gluconacetobacterer intermedius) for being used to prepare bacteria cellulose and its application, the bacterial strain is deposited in Guangdong Province's Culture Collection on the 4th in August in 2017, and preserving number is GDMCC NO:60218.And the method that bacteria cellulose is prepared using the gluconacetobacter is provided, the bacteria cellulose prepared, compared with other strains produce bacteria cellulose, the yield higher of bacteria cellulose prepared by the present invention, by the culture of 14 days, yield was up to more than 800mg.
Description
Technical field
The present invention relates to biological technical field, more particularly to a kind of middle glucose vinegar bar for being used to prepare bacteria cellulose
Bacterium and the method for preparing bacteria cellulose using the middle gluconacetobacter, the bacterial strain are middle gluconacetobacter
(Gluconacetobacterer intermedius), is deposited in Guangdong Province's Microbiological Culture Collection on 4th in August in 2017
Center, preserving number are GDMCC NO:60218.
Background technology
Cellulose (cellulose), is the main constituents of plant cell wall, but other biological such as algae, Mycophyta
And bacterium class can also produce.However, bacteria cellulose (BC, bacterial cellulose) be one kind by all kinds of bacteriums
The exocellular polysaccharide (exopolysaccharide) generated is formed, representational bacterium have acetic acid Pseudomonas (acetobacter, after
It is continuous to be renamed as gluconobacter suboxydans category), rhizobium (Rhizobium), pseudomonas (Pseudomonas) etc..In Christian era
After 1838 find first, until 1931 start formal scientific research, so that first scientific literature is delivered, more in 1982
Year is met the safe material of GRAS (being generally recognized as safety) by U.S. FDA identification.
The chemical composition of bacteria cellulose and plant cellulose is in fact identical, but bacteria cellulose has some speciality, all
The characteristics such as the high-adaptability such as high-purity, moisture holding capacity, high-tensile strength and to live body, make it can be widely applied to food addition, electricity
Sub- product, medical equipment etc..
Its characteristic includes the pure biological fiber for possessing medical grade.The 3D structures provided via nano level fiber are formed more
Careful net structure.Moisture and gas are allowed to penetrate through bacteria cellulose, and aqueous solution can not be by, therefore skin can be protected
The substantial amounts of water of breath bacteria cellulose receiving is held, and embodies and is not easy dry attribute, to prevent the volatilization of active ingredient.
From the origin of microbial project, medical field bacteria cellulose is widely used in artificial blood vessel abroad and corium produces
Product.Because 99% cellulose, it and biology are compatible, and will not stimulate skin, and under normal conditions, final products
All it may be reused, thus it is environmentally friendly.
The content of the invention
In order to solve how to prepare the bacteria cellulose of good performance of high yield, the present invention proposes a kind of middle glucose vinegar
Bacillus and its application.
The technical problem of the present invention is solved by following technical solution:
A kind of middle gluconacetobacter, the bacterial strain are identified as middle gluconacetobacter (Gluconacetobacterer
Intermedius), which is deposited in Guangdong Province's Culture Collection on 4th in August in 2017, and preserving number is
GDMCC NO:60218.
Middle gluconacetobacter (Gluconacetobacterer intermedius) provided by the invention, is named as YA-
001, Guangdong Province's Culture Collection (English name China General are deposited within 4th in August in 2017
Microbiologial Collection Center, abbreviation GDMCC, address is:The compound 59 of Xianlie Middle Road, Guangzhou City 100
5 building, building), preserving number is GDMCC NO:60218.Middle gluconacetobacter (Gluconacetobacterer intermedius)
YA-001DMCC NO:60218 referred to as middle gluconacetobacter YA-001.The middle gluconacetobacter YA-001 can be used for producing
Bacteria cellulose, and by the bacteria cellulose for manufacturing dressing.
A kind of method using above-mentioned middle gluconacetobacter production bacteria cellulose, including step:By the middle Portugal
Sweet and sour bacillus culture medium with the first temperature culture at the first time, afterwards with the second time of second temperature culture, finally with the 3rd
The 3rd time of temperature culture, obtain the bacteria cellulose;Wherein described first temperature and the 3rd temperature are less than second temperature.
Preferably, at 10~18 DEG C, incubation time is 15~18h for first temperature or second temperature control.
Preferably, for the high-temperature control at 30~35 DEG C, incubation time is 45~54h.
Preferably, the culture medium includes:Glucose is about 11g/L, peptone is about 18g/L, yeast extract is about
10g/L, disodium hydrogen phosphate are about 3.9g/L and citric acid is about 4.2g/L, the percentage about referred in corresponding numerical value
In the error range of point.
Preferably, the ratio of the first time and the incubation time of second time and the 3rd time is 1:3:
1。
Preferably, it is additionally included in the culture medium to add and supports film, the bacteria cellulose is attached on the support film.
Further, the material for supporting film includes adhesive-bonded fabric, reticular fibre cloth, nanofiber, macromolecule, waterproof
One or more in cloth, polymer foam or stationery.
The present invention also proposes the bacterial fibers that a kind of method using any of the above-described production bacteria cellulose obtains
Application of the element in manufacture dressing.
Preferably, the dressing includes drug paste or facial mask.
Preferably, the facial mask is about 90% including probiotics fermention thing, and trehalose is about 1%, and glucan is about 1%,
Vitamin B3 is about 1%, and ceramide is about 1%, and collagen is about 1%, and sodium hyaluronate is about 1%, and aloe extract is about
1%, rose extract is about 1%, and mandarin orange fruit extract is about 1%, and jasmine extract is about 0.5%, and bergamot extract is about
0.5%, it is described about to refer in the error range of the one percentage point of corresponding numerical value.
The beneficial effect that the present invention is compared with the prior art includes:Grape acetobacter of the present invention is used for what is produced
Bacteria cellulose, compared with other strains produce bacteria cellulose, the yield higher of bacteria cellulose produced by the invention, passes through
The culture of 14 days, yield are up to more than mg more than 800.Using the bacteria cellulose material, the importing excellent to anti-inflammatory agents,
Absorption rate when using traditional medical gauze is much larger than to the absorption rates of anti-inflammatory agents.
Brief description of the drawings
Fig. 1 is the SEM figures of bacteria cellulose in the specific embodiment of the invention, and wherein a and b is specific embodiment party of the present invention
Section photo of the bacteria cellulose under 15.0KV*5.0K in formula, c and d are bacterial fibers material in the specific embodiment of the invention
Expect the section photo under 15.0KV*1.0K.
Fig. 2 is the absorption curve figure of the Diclofenac drug paste that slight fiber element makes in the specific embodiment of the invention.
Fig. 3 is to expand ribosomal gene fragment result in the specific embodiment of the invention.
Fig. 4 is the testing result that PCR is extended in the specific embodiment of the invention.
Fig. 5 is the phyletic evolution tree graph of the general sweet and sour bacillus in the specific embodiment of the invention.Glucose vinegar among of the invention
The preservation date of bacillus is August in 2017 4 days, and depositary institution is Guangdong Province's Culture Collection (China General
Microbiologial Collection Center, CGMCC), preserving number is GDMCC NO:60218.
Fig. 6 is other strains and gluconacetobacter generation bacteria cellulose among the present invention in the specific embodiment of the invention
Yield mapping.
Embodiment
Below against attached drawing and with reference to preferred embodiment, the invention will be further described.
Exist using the method for above-mentioned middle gluconacetobacter production bacteria cellulose, including by the middle gluconacetobacter
Culture medium at the first time, cultivated for the second time with second afterwards with the first temperature culture, finally with the timing of second temperature culture one
Between, obtain the bacteria cellulose.In the present embodiment, control at 10~18 DEG C, incubation time is 15~18h, high-temperature control
At 30~35 DEG C, incubation time is 45~54h.In a further embodiment, first temperature and the high temperature and described the
The incubation time of two temperature can also be controlled 1:3:1.The culture medium that this method is used includes:Glucose 11g/L, peptone
18g/L, yeast extract 10g/L, disodium hydrogen phosphate 3.9g/L and citric acid 4.2g/L.It is thin with difference in functionality in order to obtain
Fungin can add support film at the same time when cultivating bacteria cellulose, according to the difference of functional requirement, support the material of film
Can be that adhesive-bonded fabric, reticular fibre cloth, nanofiber, macromolecule, waterproof cloth, polymer foam or stationery are any or more
Kind.It should be noted that it is described support film refer to for make the cellulose of culture be attached to above and the carrier that plays a supportive role.
The bacteria cellulose produced needs to use after sterilizing 15 minutes at 121 degree Celsius, and Fig. 1 is that the present invention does not add
Support the SEM figures (scanning electron microscope (SEM) photograph) of the bacteria cellulose of film, a and b is the bacteria cellulose under low power number, it can be seen that it is layered
Substantially, from the SM it can be seen from the figure thats of c and d high magnification numbes, its surface is smooth, close structure.
The bacteria cellulose of production can be applied in terms of dressing, may be used as drug paste, such as Diclofenac is loaded
Membranaceous cellulose, and it is affixed on after mouse ear using Diclofenac as anti-inflammatory agents and its degree of absorption is surveyed after absorption, tie
Fruit such as Fig. 2, it can be by absorption 90% in 10 minutes as seen from the figure, its speed is much larger than the gauze covering side in general curative
Method, imports excellent.
The bacteria cellulose of production is also used as facial mask, such as the one of which facial mask of production includes:Probiotics fermention
Thing 90%, trehalose 1%, glucan 1%, vitamin B3 1%, Cer EOS %, collagen 1%, sodium hyaluronate 1%, reed
Luxuriant growth extract 1%, rose extract 1%, mandarin orange fruit extract 1%, jasmine extract 0.5%, bergamot extract 0.5%, its
Middle % represents mass ratio.This facial mask has effects that releive face and increase moisturizing.
The identification of middle gluconacetobacter
The extraction of DNA
Thalline is put into the mortar of liquid nitrogen precooling after DNA extraction collections are cultivated 3 days, and the liquid that whole thalline was covered in addition is ground
Nitrogen is ground, and is repeated twice to three times grinding thalline completely, addition 750mL lysis buffers after dissolving (50mM Tris-HCl,
20mM EDTA-Na2,3%SDS, 1%2- thioglycols, pH=7), 1.5mL lapping liquids are taken after mixing to microcentrifugal tube, in
Reacted 30 minutes in dry bath at 65 DEG C, and not timing is stirred with toothpick, is then centrifuged (12000xg, 5min) and is collected
Layer liquid is positioned over new microcentrifugal tube, adds the PCI (phenol of equivalent:Chloroform:Isoamyl alcohol/25:24:1) it is carefully turned over for several times
Afterwards and centrifuge (12000xg, 10 minutes) and take upper liquid, add equivalent PCI be mixed after centrifuge (12000xg, 10 minutes), weight
Multiple this step 3~4 time to no protein layer separates out.After drawing upper liquid, be incorporated as the isopropanol of 0.6 times of upper liquid volume with for
The sodium acetate (pH4.8) for the 3M that 0.1 times of upper liquid volume, is positioned over -20 DEG C of refrigerators 10~60 minutes after being carefully turned over 5 times, connect
(12000xg, 1 minute) removal upper liquid is centrifuged after taking-up, to be air-dried after 75% alcohol washes to after there is no alcohol smell completely,
Back dissolving is in RNase solution As (1M, the Tris-HCl of 100mL:The ribonuclease A of 1%, 0.5M EDTA, pH8,20 μ g/mL)
After addition, be positioned over 37 DEG C, 1~2 it is small when after add after 200 μ L of chloroform overturn 5 times after centrifuge (12000xg, 5 minutes) and take upper strata
Liquid, is added the isopropanol of 0.6 times of volume and sodium acetate (pH4.8) the precipitation DNA of 0.1 times of 3M, is placed with 75% alcohol washes DNA
Air-dried in 60 DEG C of dry bath grooves to after there is no alcohol smell completely, with 65 DEG C of deionized water back dissolvings of 30 μ L, take 2 μ LDNA with 0.8%
Agar gel electrophoresis are observed, and determine to have extracted the DNA of the bacterium.
The amplification of ribosomal gene
This experiment is with 16S introduction (primers Fs:AGAGTTTGATCCTGGCTCAG, primer R:GGCTACCTTG
TTACGACTT), ribosomal gene is expanded using polymerase chain reaction (polymerase chain reaction, PCR), PCR's is set as 94
DEG C, 5 minutes, then with 94 DEG C/30 seconds, 54 DEG C/30 seconds, circulation in 72 DEG C/2 minutes carried out 30 times, finally with 72 DEG C/after five minutes
Terminate.The clean/Gel Extraction Kit (cleaning/gel extraction kit) of BioKit are used afterwards, are firstly added
The Binding Buffer (combination buffer) of amount (50 μ L) are mixed afterwards, move to centrifugation after the collecting pipe of column spinner
(12000xg, one minute), outwells the liquid in Collection tube (collecting pipe), adds the lavation buffer solution of 600 μ L
Centrifuge (12000xg, one minute) afterwards remove collecting pipe in liquid, repeat once after directly idle running centrifugation (12000xg, three
Minute), column spinner is then moved to new pipe, adds the deionized water of 50~100 μ L, is centrifuged after standing three minutes
(12000xg, three minutes), is removed rotation column, takes 2 μ L to be observed with 0.8~1.0% agar gel electrophoresis, as shown in figure 3, fragment is big
Small about 1500bp, close to the size for the fragment estimated, has successfully expanded 16S rDNA fragments.
The choosing of ribosomal gene is grown
Vector in ribosomal gene after cleaning and yT&AKit (YC001, yT&A) is subjected to yT&A connections at 4 DEG C,
Overnight (12 it is small when~16 it is small when) after, by 5 μ L of connection product add 100 μ L pre-productions bacillus coli DH 5 alpha gametid simultaneously
It is placed in 5 minutes on ice, then reacts 90 seconds postpositions 5 minutes on ice in 42 DEG C of water baths, adds 400 μ L's
LuriaBertanimedium culture mediums, then in 37 DEG C of incubator, shake culture 45 minutes under 225rpm, take out 100 μ L and apply
Be put in the plate of LB+ ampicillins (100 μ g/mL) (be coated in advance with 40 μ L2%X-gal and 7 μ L0.5M isopropyisulfanyls-β-
Galactoside (IPTG)), it is positioned over 37 DEG C of incubator culture.The white single bacterium colony on LB+ ampicillin plates is selected, is connect
Kind continues to cultivate (37 DEG C, 225rpm, O/N) in the incubator, draws afterwards to the nutrient solution of 2mL LB+Amplicillin
The pipe centrifugation (12000 xg, 1 minute) of the bacterium solution of 0.8~1mL to 1.5mL leave thalline after removing upper liquid afterwards, use
BioKit plasmid miniprep Kit (BioKit plasmid miniprep kits) carry out the extraction of plastid, are firstly added
Appropriate solution (such as solution of Bio-P100 30ml, Bio-P300 70ml) to the vortex after thalline of 200 μ L mixes, and is subsequently added into
Slightly upset pipe 5~10 times afterwards of the appropriate solution (being same as above) of 200 μ L, the appropriate solution (being same as above) for adding 200 μ L is slight afterwards
Overturn pipe 5~10 times, then centrifuging (12000xg, 10 minutes), absorption upper liquid is inserted in the collecting pipe of column spinner afterwards, is centrifuged
(12000xg, 1 minute) removes filtrate afterwards, and the lavation buffer solution of 600 μ L is added in Spin column column spinners
(Washing Buffer) centrifuges (12000xg, 1 minute) and removes filtrate and repeat this step once afterwards, then centrifuges
Column spinner is moved to new pipe after (12000xg, one minute), three minutes are stood after adding the deionized water of 50~100 μ L, then with
Centrifugation (12000xg, 3 minutes) makes plastid remove rotation column after collecting to pipe, draws 2 μ L plastids with 0.8~1.0% agar gel electrophoresis
Observe result.Plastid is diluted 200 times as template using deionized water, PCR amplification setting is the same, after amplification, takes 2 μ L with 0.8
~1.0% agar gel electrophoresis observation is as a result, as shown in figure 4, transition strain 2,6,7 can not measure ribosomes Insert Fragment, but its
He has successfully amplified expected fragment at the strain that makes the transition, followed by Genetic relationship.Transition strain 1 is chosen, and with
Automatic sequencing instrument measures vector insert gene order, obtains the fragment that 1 section of sequence fragment length is 1480bp.
Genetic relationship
YT&A carriers containing ribosomal gene sequence are carried out to the sequencing at 5' and 3' both ends with automatic nucleic acid sequencing instrument, it is fixed
Sequence result recycles the integration of software sequence, you can obtains the sequence of Rumen Fungi 18S rDNAs.In addition from NCBI data
The ribosomal gene sequence of reference strain is downloaded in storehouse, and the ribosomal gene that these sequences and this experiment are made with
After ClustalW multiple labellings are ranked up, using software MEGA6.0, with adjacent method (NJ) analysis bacterial strain and other reference strains
Affiliation, as shown in figure 5, showing the new strain branch.
Living resources preserve and research center (Bioresource Collection and Research Center,
BCRC Komagataeibacter hansenii, Cellulomonas uda, Komagataeibacter xylinus) are obtained,
The strains such as Komagataeibacter europaeus and Gluconacetobacter europaeus and YA-001 (this hair
Strain in bright) with respective some days of strain appropriate culture medium culture after, collect respective product and registered its yield, as a result
As shown in fig. 6, compared with other strains, it can be seen that the yield of YA-001 is located for 4 days, 7 days and 14 days always in different time sections
In leading position, by the culture of 14 days, final yield reached more than 820mg.
Above content is that a further detailed description of the present invention in conjunction with specific preferred embodiments, it is impossible to is assert
The specific implementation of the present invention is confined to these explanations.For those skilled in the art, do not taking off
On the premise of from present inventive concept, some equivalent substitutes or obvious modification can also be made, and performance or purposes are identical, all should
When being considered as belonging to protection scope of the present invention.
Claims (11)
1. a kind of middle gluconacetobacter for being used to prepare bacteria cellulose, the middle gluconacetobacter are named as YA-001,
Deposit number is GDMCC NO:60218.
2. a kind of method that middle gluconacetobacter using described in claim 1 prepares bacteria cellulose, it is characterised in that bag
Include following steps:By the middle gluconacetobacter in culture medium with the first temperature culture first time, afterwards with second temperature
Cultivated for the second time, finally with the 3rd time of the 3rd temperature culture, obtain the bacteria cellulose;Wherein described first temperature and
3rd temperature is less than second temperature.
3. the method that gluconacetobacter prepares bacteria cellulose among as claimed in claim 2, it is characterised in that described first
At 10~18 DEG C, incubation time is 15~18h for temperature or second temperature control.
4. the method that gluconacetobacter prepares bacteria cellulose among as claimed in claim 2, it is characterised in that the high temperature
At 30~35 DEG C, incubation time is 45~54h for control.
5. the method that gluconacetobacter prepares bacteria cellulose among as claimed in claim 2, it is characterised in that the culture
Base includes:Glucose is about 11g/L, peptone is about 18g/L, yeast extract is about 10g/L, disodium hydrogen phosphate is about
3.9g/L and citric acid are about 4.2g/L, described about to refer in the error range of the one percentage point of corresponding numerical value.
6. the method that gluconacetobacter prepares bacteria cellulose among as claimed in claim 2, it is characterised in that described first
Time is 1 with the proportionate relationship of second time and the 3rd time:3:1.
7. the method that gluconacetobacter prepares bacteria cellulose among as claimed in claim 2, it is characterised in that be additionally included in
Added in the culture medium and support film, the bacteria cellulose is attached on the support film.
8. the method that gluconacetobacter prepares bacteria cellulose among as claimed in claim 7, it is characterised in that the support
The material of film includes one kind in adhesive-bonded fabric, reticular fibre cloth, nanofiber, macromolecule, waterproof cloth, polymer foam or stationery
It is or a variety of.
9. a kind of bacteria cellulose obtained using any methods for preparing bacteria cellulose of claim 1-8 is being manufactured
The application of dressing.
10. as claimed in claim 9 in the application of manufacture dressing, it is characterised in that the dressing includes drug paste or facial mask.
11. as claimed in claim 10 in the application of manufacture dressing, it is characterised in that the facial mask includes prebiotic by weight
Bacterium fermentate is about 90%, and trehalose is about 1%, and glucan is about 1%, and vitamin B3 is about 1%, and ceramide is about 1%,
Collagen is about 1%, and sodium hyaluronate is about 1%, and aloe extract is about 1%, and rose extract is about 1%, mandarin orange fruit extract
About 1%, jasmine extract is about 0.5%, and bergamot extract is about 0.5%, described about to refer to the one of corresponding numerical value
Percentage point error range in.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711434866.3A CN108018240A (en) | 2017-12-26 | 2017-12-26 | A kind of middle gluconacetobacter and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711434866.3A CN108018240A (en) | 2017-12-26 | 2017-12-26 | A kind of middle gluconacetobacter and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108018240A true CN108018240A (en) | 2018-05-11 |
Family
ID=62071413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711434866.3A Pending CN108018240A (en) | 2017-12-26 | 2017-12-26 | A kind of middle gluconacetobacter and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108018240A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113355377A (en) * | 2020-03-03 | 2021-09-07 | 株式会社现代百朗德 | Mixed bacteria cellulose facial mask with skin microbial population regulating effect and preparation method thereof |
WO2023218226A1 (en) * | 2022-05-12 | 2023-11-16 | Polybion S.L. | Method for growing a biomaterial onto a substrate using a floating rafting system |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101503663A (en) * | 2008-12-25 | 2009-08-12 | 四川大学 | A strain of Acetobacter gluconicum and screen purification method thereof |
US20110218297A1 (en) * | 2010-03-03 | 2011-09-08 | Samsung Electronics Co., Ltd. | Novel gluconacetobacter strain having cellulose producing activity |
CN103667148A (en) * | 2013-12-14 | 2014-03-26 | 江南大学 | High-temperature resistant gluconacetobacter intermedius for producing bacterial cellulose in high-yield manner |
CN104995308A (en) * | 2012-12-28 | 2015-10-21 | 田岛健次 | Bacterial cellulose and bacterium producing same |
-
2017
- 2017-12-26 CN CN201711434866.3A patent/CN108018240A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101503663A (en) * | 2008-12-25 | 2009-08-12 | 四川大学 | A strain of Acetobacter gluconicum and screen purification method thereof |
US20110218297A1 (en) * | 2010-03-03 | 2011-09-08 | Samsung Electronics Co., Ltd. | Novel gluconacetobacter strain having cellulose producing activity |
CN104995308A (en) * | 2012-12-28 | 2015-10-21 | 田岛健次 | Bacterial cellulose and bacterium producing same |
CN103667148A (en) * | 2013-12-14 | 2014-03-26 | 江南大学 | High-temperature resistant gluconacetobacter intermedius for producing bacterial cellulose in high-yield manner |
Non-Patent Citations (3)
Title |
---|
NEHA TYAGI等: ""Production of cellulose from sugarcane molasses using Gluconacetobacter intermedius SNT-1: optimization & characterization"", 《JOURNAL OF CLEANER PRODUCTION》 * |
于永玉等: "《中华传统美德百字经 新 开拓创新》", 31 October 2010, 大众文艺出版社 * |
冯劲等: ""一株产细菌纤维素菌株的筛选鉴定及其产物分析"", 《生物技术通报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113355377A (en) * | 2020-03-03 | 2021-09-07 | 株式会社现代百朗德 | Mixed bacteria cellulose facial mask with skin microbial population regulating effect and preparation method thereof |
WO2023218226A1 (en) * | 2022-05-12 | 2023-11-16 | Polybion S.L. | Method for growing a biomaterial onto a substrate using a floating rafting system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103667187B (en) | A kind of isolated culture method of human adipose-derived stem cell and the construction method of stem cell bank | |
Pletikapić et al. | AFM imaging of extracellular polymer release by marine diatom Cylindrotheca closterium (Ehrenberg) Reiman & JC Lewin | |
CN110250210B (en) | Optimal DSE strain for promoting corn seed soaking and rooting | |
CN111513077B (en) | RNAi nano preparation, preparation method thereof and application thereof in TMV prevention and treatment | |
CN107475187A (en) | Nutrient solution and a large amount of production technologies for obtaining umbilical cord mesenchymal stem cells excretion body | |
CN110200018B (en) | Optimal DSE inoculation amount for promoting plant rooting | |
CN106520591A (en) | Germination-promoting bacillus and application thereof | |
CN108018240A (en) | A kind of middle gluconacetobacter and its application | |
CN108273496A (en) | A kind of preparation method and applications of the bionic enzyme based on bacteria cellulose | |
CN105177124A (en) | Preparation method of cell-origin quality control substance | |
CN107488607B (en) | Separation identification and application of bacterial cellulose producing strain | |
CN108841748A (en) | Sinorhizobium nitrogen-fixing bacteria strain H6 and its application | |
CN105420167B (en) | A kind of Bacillus cercus and its application | |
CN110616150B (en) | High-yield polysaccharide eupatorium adenophorum endophytic fungus and application thereof | |
CN115287225B (en) | Stenotrophomonas strain KC098, fermentation liquor and application thereof | |
CN110343648A (en) | A kind of method of simple separate tobacco ralstonia solanacearum | |
CN116509764A (en) | Yeast fermentation product filtrate containing recombinant type 17 human collagen | |
CN115927016A (en) | Dahurian rhodophyllum boletus strain and application thereof | |
CN106769298B (en) | A kind of microscopy observation method of plant tissue | |
CN102199615A (en) | cDNA sequence coding fibrinolysin, amino acid sequence and applications of sequences | |
CN105176812B (en) | A kind of cutting separation propagating method of stem cell sphere cutting collection device and stem cell sphere | |
CN106754647A (en) | A kind of separation of giant salamander skin epidermal cells, culture and authentication method | |
CN113106059A (en) | High-migration mesenchymal stem cell and preparation method and application thereof | |
CN101717783B (en) | Universal expression vector for large transgenic green alga and transformation expression method thereof | |
CN107349466A (en) | The preparation method of three-dimensional cell support based on collagen sponge nano-cellulose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180511 |